Abstract
The Editor-in-Chief of DNA and Cell Biology officially retracts the article entitled, “miR-142 Suppresses Endometrial Cancer Proliferation In Vitro and In Vivo by Targeting Cyclin D1” by Su Y, Wang J, Ma Z, Gong W, Yu L. (DNA Cell Biol. 2019;38(2):144–150; 10.1089/dna.2018.4441) due to apparent duplication of images published in another journal 1 and after receiving a report by the PRIMeR group out of the University of Sydney (Australia) led by Professor Jennifer Byrne, identifying that the ACTB forward and reverse primers provided under the section quantitative real-time PCR are primers targeting ACTB within Rattus rattus, not humans. Within the human transcriptome, they would be expected to also target two separate genes (forward: ACTG1, reverse: ACTC1). The Editor agrees with the report.
The authors were contacted via email of the reported issues utilizing the email addresses provided to the journal at the time of submission in 2018, though no response was received.
The Editor and Publisher of DNA and Cell Biology are committed to preserving the veracity of scientific literature and the community it serves.